E019 A case of RS3PE triggered by immune check point inhibitor
Sign Up to like & getrecommendations! Published in 2023 at "Rheumatology"
DOI: 10.1093/rheumatology/kead104.268
Abstract: Immune checkpoint inhibitors (ICIs) are increasingly being used in oncology and there is growing evidence of rheumatological problems arising in these group of patients. ICIs have been approved for the treatment of several cancers including… read more here.
Keywords: lung cancer; therapy; pedal oedema; case ... See more keywords